{
  "id": "SCR-LIP-000779",
  "statement": "Depressive and anxiety symptoms are frequently reported in people with lipedema, though evidence on whether they exceed those in women with comparable obesity is inconsistent.",
  "claim_type": "clinical_association",
  "context": {
    "population": "lipedema patients vs matched population controls",
    "condition": "lipedema",
    "exposure": "lipedema diagnosis",
    "comparator": "sex-, age-, BMI-matched population controls",
    "outcome": "depression, pain, social contacts, health status",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "ref": "DOI:10.3390/life14030295",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2024,
      "amato_authored": false,
      "note": "Cross-sectional questionnaire study with BMI/age/sex-matched controls directly measuring quality of life, depression (PHQ-8), pain and social outcomes in lipedema patients, showing significantly worse mental health and QoL outcomes. [grade capped moderate->low per curated Oxford N4]",
      "title": "Health Implications of Lipedema: Analysis of Patient Questionnaires and Population-Based Matched Controls",
      "authors": "Kempa et al.",
      "journal": "Life",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. All specific figures in the statement (43.6% vs 18.5% depression, p=0.001; PHQ-8 depressive symptoms 89.7% vs 39.3%; rho=0.612, p<0.001; matched for sex, age, BMI) are directly supported by",
        "date": "2026-06-10"
      },
      "quote": "Depressao autorrelatada nos ultimos 12 meses em 43,6% do grupo lipedema vs 18,5% dos controles (p=0,001); pelo PHQ-8, apenas 10,3% dos pacientes nao tinham sintomas depressivos vs 60,7% dos controles",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Vs population controls matched for sex, age and BMI: self-reported depression 43.6% vs 18.5% (p=0.001); PHQ-8 depressive symptoms in 89.7% vs 39.3%.",
      "from_claims": [
        "SCR-LIP-000169"
      ]
    },
    {
      "ref": "DOI:10.3389/fgwh.2025.1629077",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2025,
      "amato_authored": false,
      "note": "Cross-sectional observational study directly measuring depression (PHQ-9), quality of life (WHOQOL-BREF), and symptom associations in lipedema patients; small sample (n=43) and chi-square associations are unadjusted, limiting strength.",
      "title": "Mental and physical health burden and quality of life in Czech women with lipedema",
      "authors": "Kunzová et al.",
      "journal": "Frontiers in Global Women's Health",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "All specific figures in the statement (n=43, 50.9% moderate-to-severe PHQ-9, psychological domain 46.3, physical domain 50.8, psychological domain most affected, and the five symptoms significantly associated with depression) are directly s",
        "date": "2026-06-10"
      },
      "quote": "mais da metade apresenta sintomas depressivos moderados a severos e a qualidade de vida é baixa em múltiplos domínios, com o domínio psicológico o mais afetado",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In 43 Czech women, 50.9% had moderate-to-severe depressive symptoms (PHQ-9 >=10); WHOQOL-BREF psychological domain most affected (46.3).",
      "from_claims": [
        "SCR-LIP-000167"
      ]
    },
    {
      "ref": "DOI:10.12740/app/201427",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2025,
      "amato_authored": false,
      "note": "Narrative review (no original intervention) summarizing observational and survey studies that consistently report impaired quality of life, elevated anxiety, depressive symptoms, and emotional/behavioral disturbances in lipedema patients, d",
      "title": "Lipedema: The intersection of physical and mental health",
      "authors": "Janota et al.",
      "journal": "Archives of Psychiatry and Psychotherapy",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "All specific findings cited in the statement (Al-Wardat DERS/HAM-A with 26 vs 26, Chachaj behavioral disturbances vs overweight/obese controls, Cagliyan Turk depressive/anxious symptoms with fibromyalgia, Clarke 51-73% occupational limitati",
        "date": "2026-06-10"
      },
      "quote": "pacientes com lipedema mostraram dificuldade significativamente maior na regulação emocional e níveis mais altos de ansiedade",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Narrative review reports greater emotional dysregulation and higher anxiety than controls, behavioural disturbances vs overweight controls, and occupational limitations.",
      "from_claims": [
        "SCR-LIP-000350"
      ]
    },
    {
      "ref": "DOI:10.1007/s40519-019-00703-x",
      "stance": "context",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2019,
      "amato_authored": false,
      "note": "Narrative review synthesizing four moderate-quality cross-sectional studies directly measuring HRQOL and psychological status in lipedema; all studies cross-sectional preventing causal inference, with heterogeneous instruments precluding me",
      "title": "The effect of lipedema on health-related quality of life and psychological status: a narrative review of the literature",
      "authors": "Alwardat et al.",
      "journal": "Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": false,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "Human review: synthesis — this scoping review supports the QoL findings (EQ-5D/WHOQOL); the specific depression percentages are from a sibling source (integrity clean). Accepted.",
        "date": "2026-06-10",
        "reviewed_by": "Amato (ORCID 0000-0003-4008-4029)",
        "reviewed_date": "2026-06-12"
      },
      "quote": "Ansiedade/depressão em 42,0% (1,2% extremamente) DUDEK 2019 (n=328, online, WHOQOL-BREF): maior coorte de QoL no lipedema. HRQOL inversamente correlacionada com: severidade de sintomas (r=-0,651), depressão (r=-0,750), distress de aparência (r=-0,654)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Narrative review: anxiety/depression in 42.0%; HRQoL inversely correlated with symptom severity (r=-0.651), depression (r=-0.750) and appearance distress (r=-0.654) in the largest cohort.",
      "from_claims": [
        "SCR-LIP-000171"
      ],
      "secondary_of": "DOI:10.1080/13548506.2018.1459750"
    },
    {
      "ref": "DOI:10.17219/acem/181146",
      "stance": "refines",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2024,
      "amato_authored": false,
      "note": "Cross-sectional baseline comparison directly measuring disability, depression, and anxiety in lipedema vs overweight/obese controls; disability worse even after BMI adjustment, but emotional symptoms did not differ, refining the question's  [grade capped moderate->low per curated Oxford N4]",
      "title": "Disability and emotional symptoms in women with lipedema: A comparison with overweight/obese women",
      "authors": "Chachaj et al.",
      "journal": "Advances in Clinical and Experimental Medicine",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article directly reports all the specific statistics cited in the statement (WHO-DAS II domains, Z-scores, p-values, BDI-II medians, HADS scores) and the findings match exactly: greater",
        "date": "2026-06-10"
      },
      "quote": "NENHUMA diferenca significativa entre grupos em sintomas emocionais: BDI-II mediana 11,00 (lipedema) vs 8,00 (obesidade) p=0,130; HADS-A 9,16 +/- 3,59 vs 8,10 +/- 3,35 p=0,162; HADS-D 5,00 vs 6,00 p=0,474 -- nem antes nem depois do ajuste por BMI.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "refines",
      "finding": "Vs overweight/obese women, no significant differences in depression or anxiety (BDI-II 11 vs 8, p=0.130; HADS-A p=0.162) before or after BMI adjustment, while WHO-DAS II disability was greater (social participation p=0.002).",
      "from_claims": [
        "SCR-LIP-000177"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000169",
    "SCR-LIP-000167",
    "SCR-LIP-000350",
    "SCR-LIP-000171",
    "SCR-LIP-000177"
  ],
  "questions_consolidated": [
    "SQ-LIP-000041"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00223",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round + arbitration)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000041"
    }
  ],
  "statement_pt": "Sintomas depressivos e ansiosos são frequentemente relatados em pessoas com lipedema, embora as evidências sobre se eles superam os de mulheres com obesidade comparável sejam inconsistentes.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000041",
      "role": "supporting",
      "question": "How does lipedema affect health-related quality of life?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000041.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000779.html"
}